Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Microcap & Penny Stocks : Computerized Thermal Imaging CIO (formerly COII) -- Ignore unavailable to you. Want to Upgrade?

To: Gwolf who wrote (293)	5/8/1998 11:22:00 AM
From: Bill Story	Read Replies (1) \| Respond to of 6039

To Anyone, Can someone explain what Fully Reporting is? Thanks, Bill

To: Gwolf who wrote (293)	5/9/1998 9:04:00 AM
From: Mr.D	Read Replies (1) \| Respond to of 6039

I think your going to see some DGIV money come over here soon. I have about 150000 sh. At this time I have been putting my $ in DGIV but I have been telling my friends about this stock for months...Good luck to you all..Bill D.

To: Gwolf who wrote (293)	5/9/1998 10:40:00 AM
From: chirodoc	Respond to of 6039

here is the press release gwolf is talking about: SOURCE: Computerized Thermal Imaging, Inc. CTI Clinical Trial Aimed at Reducing 'False Positive' Mammograms OGDEN, Utah, May 4 /PRNewswire/ -- Computerized Thermal Imaging, Inc. (OTC Bulletin Board: COII - news; CTI) said today that the clinical trials of its proprietary Computerized Thermal Imaging technology being conducted by its 80 percent owned subsidiary, Thermal Medical Imaging is seeking to reduce the number of ''false positive'' findings associated with mammography, and thus reduce the number of benign biopsies. CTI's technology uses a sophisticated heat sensitive camera to record an image of the heat produced by breast tissue. The image is processed by a proprietary computer program designed to identify minute thermal deviations, which aid in the differentiation of healthy from suspicious tissue. The procedure is painless and requires no exposure to radiation or breast compression. David A. Packer, president of CTI, said, ''the power of our technology is that it is aimed at reducing false positive readings and benign biopsies. At the present time, surgeons are unable to determine whether a growth is benign or malignant without a biopsy, and yet we know that up to 75% of the biopsies yield benign results. ''A study recently published in the New England Journal of Medicine reported that the estimated cumulative risk of a false positive result is nearly 50 percent after 10 mammograms. It further noted that over a period of 10 years, one third of the women screened had abnormal test results requiring additional evaluation, even though no breast cancer was present. ''The study further reported that three months after a false positive mammogram, 47% of women who had a highly suspicious reading reported that they had substantial anxiety related to the mammogram, 26% said the worry affected their daily mood and 17% said it affected their daily function. It concluded that 'techniques are needed to decrease false positive results while maintaining high sensitivity.' ''Our technology seeks to determine, without having to perform a biopsy, whether a particular breast tumor is benign or malignant, thus reducing the large number of benign biopsies, and saving women from the physical and emotional stress associated with surgery, not to mention the substantial savings to the health care system,'' Mr. Packer added. The clinical trials are being conducted at USC/Norris Comprehensive Cancer Center and Los Angeles County Hospital as well as Providence Hospital in Washington D.C. Final preparations are underway to open an additional trial site at a large hospital in the next few weeks. Trials are expected to be completed later this year. Computerized Thermal Imaging, Inc. develops thermal imaging and associated technologies for use in the enhancement of medical screening, diagnosis and patient management. More information about CTI can be found on the Internet at www.cti-net.com or by calling CTI Public Affairs at 801-776-4700. Except for historical information contained herein, the matters discussed in this news release are forward-looking statements that involve risks and uncertainties. The forward-looking statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. In addition to the factors set forth above, other important factors that could cause actual results to differ materially include, but are not limited to technical risks associated with new technology development, government regulatory approvals or continued working capital. Additional information concerning factors that could cause actual results to differ materially from those in the forward-looking statements in contained from time to time in the Company's SEC filings. Copies of these filings may be obtained by contacting the Company or the SEC. SOURCE: Computerized Thermal Imaging, Inc.